The clinicopathologic characteristics and prognostic significance of triple-negativity in node-negative breast cancer (2008)
Rhee, Jiyoung,
Han, Sae-Won,
Oh, Do-Youn,
Kim, Jee,
Im, Seock-Ah,
Han, Wonshik,
...
Abstract Background Triple-negative (TN) breast cancer, which is defined as being negative for the estrogen receptor (ER), the progesterone receptor (PR), and the human epidermal growth factor...
Modified FOLFOX-6 chemotherapy in advanced gastric cancer: Results of phase II study and comprehensive analysis of polymorphisms as a predictive and prognostic marker (2008)
Keam, Bhumsuk,
Im, Seock-Ah,
Han, Sae-Won,
Ham, Hye,
Kim, Min A,
Oh, Do-Youn,
...
Abstract Background The objective of this study was to evaluate the efficacy and toxicity of infusional 5-fluorouracil (5-FU), folinic acid and oxaliplatin (modified FOLFOX-6) in patients with...
Prognostic impact of clinicopathologic parameters in stage II/III breast cancer treated with neoadjuvant docetaxel and doxorubicin chemotherapy: paradoxical features of the triple negative breast cancer (2007)
Keam, Bhumsuk,
Im, Seock-Ah,
Kim, Hee-Jun,
Oh, Do-Youn,
Kim, Jee,
Lee, Se-Hoon,
...
Abstract Background Prognostic factors in locally advanced breast cancer treated with neoadjuvant chemotherapy differ from those of early breast cancer. The purpose of this study was to identify the...
Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy (2007)
Lee, Kyung-Hun,
Im, Seock-Ah,
Oh, Do-Youn,
Lee, Se-Hoon,
Chie, Eui,
Han, Wonshik,
...
Abstract Background Bcl-2 is positively regulated by hormonal receptor pathways in breast cancer. A study was conducted to assess the prognostic significances of clinico-pathologic variables and of...
Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy
Lee, Kyung-Hun,
Im, Seock-Ah,
Oh, Do-Youn,
Lee, Se-Hoon,
Chie, Eui Kyu,
Han, Wonshik,
...
Prognostic impact of clinicopathologic parameters in stage II/III breast cancer treated with neoadjuvant docetaxel and doxorubicin chemotherapy: paradoxical features of the triple negative breast cancer
Keam, Bhumsuk,
Im, Seock-Ah,
Kim, Hee-Jun,
Oh, Do-Youn,
Kim, Jee Hyun,
Lee, Se-Hoon,
...
Modified FOLFOX-6 chemotherapy in advanced gastric cancer: Results of phase II study and comprehensive analysis of polymorphisms as a predictive and prognostic marker
Keam, Bhumsuk,
Im, Seock-Ah,
Han, Sae-Won,
Ham, Hye Seon,
Kim, Min A,
Oh, Do-Youn,
...
The clinicopathologic characteristics and prognostic significance of triple-negativity in node-negative breast cancer
Rhee, Jiyoung,
Han, Sae-Won,
Oh, Do-Youn,
Kim, Jee Hyun,
Im, Seock-Ah,
Han, Wonshik,
...